Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 10/2014

01-10-2014 | Original Article

Thermal inactivation of Alkhumra hemorrhagic fever virus

Authors: Tariq A. Madani, El-Tayb M. E. Abuelzein, Esam I. Azhar, Hussein M. S. Al-Bar

Published in: Archives of Virology | Issue 10/2014

Login to get access

Abstract

The physico-chemical and biological characteristics of Alkhumra hemorrhagic fever virus (AHFV) are not yet known. The present study describes the thermal stability of this virus at different temperatures for different periods. The kinetics of thermal inactivation were studied, linear regressions were plotted, the Arrhenius equation was applied, and the activation energy was calculated accordingly. Titers of the residual virus were determined in median tissue culture infective dose (TCID50), and the rate of destruction of infectivity at various temperatures was determined. Infectivity of AHFV was completely lost upon heating for 3 minutes at 60 °C and for 30 min at 56 °C. However, the virus could maintain 33.2 % of its titer after heating for 60 min at 45 °C and 32 % of its titer after heating for 60 min at 50 °C. In conclusion, AHFV is thermo-labile, and its inactivation follows first-order kinetics.
Literature
1.
Qattan I, Akbar N, Afif H, Abu Azmah S, Al-Khateeb T, Zaki A et al (1996) A novel flavivirus: Makkah Region 1994– 1996. Saudi Epidemiol Bull 3(1):1–3 (ISSN: 1319–3965)
2.
Madani TA (2005) Alkhumra virus infection, a new viral hemorrhagic fever in Saudi Arabia. J Infect 51(2):91–97PubMedCrossRef
3.
Madani TA, Azhar EI, Abuelzein EME, Kao M, Al-Bar HMS, Abu-Araki H et al (2011) Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia. J Infect 62(1):67–76PubMedCrossRef
4.
Carletti F, Castilletti C, Di Caro A, Capobianchi MR, Nisii C, Suter F et al (2010) Alkhurma hemorrhagic fever in travellers returning from Egypt, 2010. Emerg Infect Dis 16(12):1979–1982PubMedCrossRefPubMedCentral
5.
Youngner JS (1957) Thermal inactivation studies with different strains of poliovirus. J Immunol 78:282–290PubMed
6.
7.
Koka M, Mikolajcik EM (1967) Kinetics of thermal destruction of bacteriophages active against Streptococcus cremoris. J Dairy Sci 50:1025–1031CrossRef
8.
9.
10.
Lo JP, Svehag SE, Gorham JR (1965) Thermostability of distemper virus and its neutralization by antibody. Acta Vet Scand 6:329–340PubMed
11.
Digioia GA, Licciardello JJ, Nickerson JTR, Goldblith SA (1970) Thermal inactivation of Newcastle disease virus. Appl Microbiol 19(3):454–551
12.
Abuelzein EME (1983) Study of the thermal inactivation kinetics of the red cowpox virus and its white mutant. J Vet Res 4:13–18
13.
Middleton JK, Severson TF, Chandran K, Gillian AL, Yin J, Nibert ML (2002) Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1. J Virol 76(3):1051–1061PubMedCrossRefPubMedCentral
14.
Kamolsiripichaiporn S, Subharat S, Udon R, Thongtha P, Nuanualsuwan S (2007) Thermal inactivation of foot-and mouth disease viruses in suspension. Appl Environ Microbiol 73(22):7177–7184PubMedCrossRefPubMedCentral
15.
Chambers AE, Dixon MM, Harvey SP (2009) Studies of the suitability of fowlpox as a decontamination and thermal stability simulant for variola major. Int J Microbiol 2009:158749 (9 pages)PubMedCrossRefPubMedCentral
16.
Heidelbaugh ND, Graves JH (1968) Effects of some techniques applicable in food processing on the infectivity of foot-and-mouth disease virus. J Food Technol 22:120–124
17.
Thomas C, Swayne DE (2007) Thermal inactivation of H5N1 high pathogenicity avian influenza virus in naturally infected chicken meat. J Food Prot 70(3):674–680PubMed
18.
Rechsteiner J (1969) Thermal inactivation of respiratory syncytial virus in water and hypertonic solutions. J Gen Virol 5:397–403CrossRef
19.
Hollinger FB, Dolana G, Thomas W, Gyorkey F (1984) Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate. J Infect Dis 150(2):250–262PubMedCrossRef
20.
Wiggan O, Livengood JA, Silengo SJ, Kinney RM, Osorio JE, Huang CY et al (2011) Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines. Vaccine 29(43):7456–7462PubMedCrossRefPubMedCentral
21.
Garcia F, Climent N, Guardo AC, Gil C (2013) A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med 5(166):166ra2PubMedCrossRef
22.
Muylaert IR, Galler R, Rice CM (1997) Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol 71(1):291–298PubMedPubMedCentral
23.
Brinton MA (1981) Isolation of a replication-efficient mutant of West Nile virus from a persistently infected genetically resistant mouse cell culture. J Virol 39(2):413–421PubMedPubMedCentral
24.
25.
Tarr GC, Lubiniecki AS (1976) Chemically-induced temperature sensitive mutants of dengue virus type 2. I. Isolation and partial characterization. Arch Virol 50(3):223–235PubMedCrossRef
26.
Madani TA, Kao M, Azhar EI, Abuelzein EME, Al-Bar HMS, Abu-Araki H et al (2011) Successful propagation of Alkhumra (misnamed as Alkhurma) virus in C6/36 mosquito cells. Trans R Soc Trop Med Hyg 106:180–185PubMedCrossRef
27.
Reed LJ, Muench H (1983) Simple method of estimating 50 % endpoints. Am J Hyg 27:493–497
28.
Burke DS, Monath TP (2011) Flaviviruses. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippencott-Raven, Philadelphia, pp 1046–1109
29.
Remington KM, Trego SR, Buczynski G, Li H, Osheroff WP, Brown JP et al (2004) Inactivation of West Nile virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products. Vox Sang 87:10–18PubMedCrossRef
30.
Fang Y, Brault AC, Reisen WK (2009) Short Report: Comparative thermostability of West Nile, St. Louis encephalitis, and western equine encephalomyelitis viruses during heat inactivation for serologic diagnostics. Am J Trop Med Hyg 80(5):862–863PubMed
31.
32.
Bachrach HL, Breese SS Jr, Callis JJ, Hess WR, Patty RE (1957) Inactivation of foot-and-mouth disease virus by pH and temperature changes and by formaldehyde. Proc Soc Exp Biol Med 95(1):147–152PubMedCrossRef
Metadata
Title
Thermal inactivation of Alkhumra hemorrhagic fever virus
Authors
Tariq A. Madani
El-Tayb M. E. Abuelzein
Esam I. Azhar
Hussein M. S. Al-Bar
Publication date
01-10-2014
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2014
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2134-z

Other articles of this Issue 10/2014

Archives of Virology 10/2014 Go to the issue

Annotated Sequence Record

Whole-genome analysis of porcine epidemic diarrhea virus (PEDV) from eastern China

Original Article

Immune and inflammatory response in pigs during acute influenza caused by H1N1 swine influenza virus

Original Article

Caraparu virus induces damage and alterations in antioxidant defenses in the liver of BALB/c mice after subcutaneous infection

Annotated Sequence Record

Complete sequence of a novel duck astrovirus

Brief Report

Characterization of epizootic hemorrhagic disease virus from a bovine with clinical disease with high nucleotide sequence identity to white-tailed deer isolates

Original Article

Analysis of the phylogeny of Chinese H9N2 avian influenza viruses and their pathogenicity in mice
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits